Neprinol AFD
Natural health product licensed in Canada
- Licence holder
- Arthur Andrew Medical Inc.
- NPN or DIN-HM
- 80119153
- Status
- Active licence
- Licence date
- 4 June 2022
- Revision date
- 8 August 2022
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serratiopeptidase | 45,000 SPU | Not calculated |
| Serratiopeptidase | 20.45 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 10,000 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 10.53 mg | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 500 FIP LU | Not calculated |
| Triacylglycérol lipase Source : Candida rugosa - whole | 2 mg | Not calculated |
| Protéase bactérien | 33,000 FCC PC | Not calculated |
| Protéase bactérien | 316.54 mg | Not calculated |
Non-medicinal ingredients
Gomme de gellane, Eau, Hypromellose, NA
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Mucolytic enzyme that helps break down mucous. Proteolytic Enzyme. Proteolytic enzyme that helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Digestive enzyme that helps digest proteins. Digestive enzyme(s). Source of/Provides antioxidants. Used in herbal medicine to help relieve minor pain, swelling and inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80119153
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging